The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 09, 2019

Filed:

Mar. 02, 2017
Applicant:

Nektar Therapeutics, San Francisco, CA (US);

Inventors:

Andreas Kordikowski, Hellifield, GB;

Stephen Ernest Walker, Baildon, GB;

Peter York, Ilkley, GB;

Assignee:

Nektar Therapeutics, San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4985 (2006.01); A61K 9/12 (2006.01); A61K 47/06 (2006.01); B01J 2/04 (2006.01); A61K 9/00 (2006.01); A61K 47/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4985 (2013.01); A61K 9/008 (2013.01); A61K 9/12 (2013.01); A61K 47/06 (2013.01); A61K 47/08 (2013.01); B01J 2/04 (2013.01); Y10S 514/951 (2013.01); Y10T 428/2982 (2015.01);
Abstract

Embodiments of the invention relate to particles of active substances, methods for preparing the particles, formulations containing the particles, and metered dose inhalers containing such particles or formulations. In one embodiment, a composition of an aerosol formulation is provided and contains a particulate active substance of non-micronized, solid particles having a mass median aerodynamic diameter of less than 10 μm suspended in a hydrofluorocarbon fluid vehicle at a concentration within a range from about 0.2% w/v to about 5% w/v. The aerosol formulation exhibits a flocculation volume of about 85% or greater about 1 minute after mixing the particulate active substance and the hydrofluorocarbon fluid vehicle. The particulate active substance contains an alkaloid ergotamine, pharmaceutically acceptable salts thereof, analogues thereof, or derivatives thereof. In some examples, the alkaloid ergotamine contains dihydroergotamine, such as dihydroergotamine mesylate and the hydrofluorocarbon fluid vehicle contains HFA 134a, HFA 227ea, or mixtures thereof.


Find Patent Forward Citations

Loading…